A61K 38 - Medicinal preparations containing peptides

Patents for A61K 38 - Medicinal preparations containing peptides (316,240)
12/1992
12/02/1992	EP0516135A2 Human immunodeficiency virus-related immune preparation
12/02/1992	EP0515995A2 N-(5-thioxo-L-prolyl)-L-cysteine, derivatives thereof, processes for the preparation thereof and pharmaceutical compositions containing them
12/02/1992	EP0515681A1 Peptide compound
12/02/1992	EP0515571A1 Hybrid reagents capable of selectively releasing molecules into cells
12/02/1992	EP0515569A1 Calcium channel compositions and methods
12/02/1992	EP0515550A1 Heparin neutralization with platelet factor 4
12/02/1992	EP0515494A1 Use of inhibitor of cytokine activity
12/02/1992	EP0515434A1 Method for treating intestinal diseases
12/02/1992	EP0515394A1 COVALENT ANGIOGENIN/RNase HYBRIDS
12/02/1992	EP0515386A1 Glycoalkaloids
12/02/1992	EP0496833A4 Biosynthetic constructs of tgf--g(b)
12/02/1992	EP0394283B1 Use of a tripeptide for the preparation of pharmaceutical compositions and a pharmaceutical composition and method
12/02/1992	CN1066660A Peptide compound and process for preparation thereof
12/02/1992	CN1066656A Amino acid azelidinyl substituted pyridone derivatives, their preparation and their application as medications
12/01/1992	WO1992021755A1 Treatment of hiv-associated immune thrombocytopenic purpura
12/01/1992	WO1992021372A1 Crf analogs
12/01/1992	WO1992021356A1 Hypertonic isochloremic formulation for circulatory shock
12/01/1992	US5168102 Endocrine manipulation to improve body composition of poultry
12/01/1992	US5168061 Pregnancy regulator
12/01/1992	US5168053 Ribonuclease and genetically-engineered external guide sequence of nucleotides as treatment for AIDS
12/01/1992	US5168045 Diagnostic systems and methods using polypeptide analogs of apolipoprotein e
12/01/1992	US5167957 Compositions and methods for the treatment of dietary deficiencies
12/01/1992	US5167956 Immunotoxin with in-vivo t cell suppressant activity
12/01/1992	CA2108580A1 Treatment of hiv-associated immune thrombocytopenic purpura
12/01/1992	CA2103246A1 Hypertonic isochloremic formulation for circulatory shock
12/01/1992	CA2086827A1 Crf analogs
12/01/1992	CA2069671A1 Human immunodeficiency virus-related immune preparation
12/01/1992	CA1311086C Chimeric peptides for neuropeptide delivery through the blood-brain barrier
12/01/1992	CA1310924C Infective drug delivery system
12/01/1992	CA1310902C Autocrine motility factors in cancer diagnosis and management
11/1992
11/26/1992	WO1992021033A1 Determination of motifs of peptides on mhc molecules
11/26/1992	WO1992021029A1 Selecting ligand agonists and antagonists
11/26/1992	WO1992020814A1 Gastrin-binding protein
11/26/1992	WO1992020811A2 Cloning and expression of human islet glutamic acid decarboxylase autoantigen
11/26/1992	WO1992020804A1 Atp-dependent protease and use of inhibitors for same in the treatment of cachexia and muscle wasting
11/26/1992	WO1992020799A1 Amino acid sequence of anticancer human monoclonal antibody and dna base sequence coding for the same
11/26/1992	WO1992020798A1 HEREGULINS (HRGs), BINDING PROTEINS OF P185?erb2¿
11/26/1992	WO1992020797A1 Neurotrophic factor, preparation and uses thereof
11/26/1992	WO1992020795A1 INHIBITOR OF NF-λB TRANSCRIPTIONAL ACTIVATOR AND USES THEREOF
11/26/1992	WO1992020794A1 Purification and cloning of p62
11/26/1992	WO1992020793A1 CLONING AND RECOMBINANT PRODUCTION OF RECEPTOR(S) OF THE ACTIVIN/TGF-β SUPERFAMILY
11/26/1992	WO1992020792A1 Truncated forms of the hepatocyte growth factor (hgf) receptor
11/26/1992	WO1992020790A1 Transgenic non-human animal carrying a non-infectious hiv genome
11/26/1992	WO1992020785A1 Tumor associated monoclonal antibody 81av78
11/26/1992	WO1992020715A1 Endotoxin binding and neutralizing protein and uses thereof
11/26/1992	WO1992020712A1 Leukocyte-associated cell surface protein
11/26/1992	WO1992020711A2 Lhrh antagonists and intermediate products
11/26/1992	WO1992020710A1 Grf analogs xi
11/26/1992	WO1992020709A1 Galanin antagonist
11/26/1992	WO1992020707A1 Bombesin analogs
11/26/1992	WO1992020706A1 Endothelin antagonists
11/26/1992	WO1992020703A1 The use of nucleic acid analogues in diagnostics and analytical procedures
11/26/1992	WO1992020702A1 Peptide nucleic acids
11/26/1992	WO1992020701A2 Interleukin receptor targeted molecules for treatment of accelerated atherosclerosis
11/26/1992	WO1992020647A1 Lipoaminoacids, preparation method and applications
11/26/1992	WO1992020371A1 Targeted delivery of bone growth factors
11/26/1992	WO1992020369A1 Use of hemoglobin in a method for the treatment of tumors with chemotherapeutic agents
11/26/1992	WO1992020368A1 Use of polymerized hemoglobin to increase the antitumor effect of the ionizing radiation
11/26/1992	WO1992020367A1 Treatment of anorexia and related states
11/26/1992	WO1992020366A1 Insulin and amylin containing composition for the treatment of insulin deficient mammals
11/26/1992	WO1992020365A1 Therapeutic and diagnostic methods based on neurotrophin-4 expression
11/26/1992	WO1992020363A1 Treatment of liver cancer
11/26/1992	WO1992020362A1 Nerve growth peptides and uses therefor
11/26/1992	WO1992020361A1 New combination of factor viii and an antifibrinolytic
11/26/1992	WO1992020360A1 Method of using substance p to treat allergy
11/26/1992	WO1992020357A1 Inhibitors of cathepsin g and elastase for preventing connective tissue degradation
11/26/1992	WO1992020356A1 Tumor rejection antigen precursors, tumor rejection antigens and uses thereof
11/26/1992	WO1992020354A1 Composition and method of treating depigmentation disorders
11/26/1992	WO1992020348A1 Treatment of colorectal carcinoma with antisense oligonucleotides to c-myb proto-oncogene
11/26/1992	WO1992020330A1 New thermoplastic polymeric material and process for making same
11/26/1992	WO1992020329A1 Enzyme systems
11/26/1992	WO1992020327A1 Treatment of fatigue syndrome with cholinesterase inhibitors
11/26/1992	WO1992020316A2 Targeted delivery of genes encoding immunogenic proteins
11/26/1992	WO1992018536A3 Method for detecting an localizing tissues having neurokinine 1 receptors
11/26/1992	DE4124168A1 Thromboxane A2 antagonists, esp. daltroban - used to prevent thrombosis caused by admin. of recombinant human erythropoietin
11/26/1992	DE4117507A1 Verfahren zur herstellung von n(pfeil hoch)6(pfeil hoch)-substituierten lysin-derivaten Process for the preparation of n (arrow up) 6 (arrow up) -substituted lysine derivatives
11/26/1992	CA2471093A1 Determination of motifs of peptides on mhc molecules
11/26/1992	CA2109843A1 Method of using substance p to treat allergy
11/26/1992	CA2109829A1 Treatment of colorectal carcinoma with antisense oligonucleotides to c-myb proto-oncogene
11/26/1992	CA2109805A1 The use of nucleic acid analogues in diagnostics and analytical procedures
11/26/1992	CA2109794A1 Amylin and possibly insulin containing composition for the treatment of anorexia and related states
11/26/1992	CA2109622A1 New thermoplastic polymeric material and process for making same
11/26/1992	CA2109604A1 Insulin and amylin containing composition for the treatment of insulin deficient mammals
11/26/1992	CA2109599A1 Lipopolyaminoacids, preparation and uses thereof
11/26/1992	CA2109598A1 Therapeutic and diagnostic methods based on neurotrophin-4- expression
11/26/1992	CA2109503A1 Galanin antagonist
11/26/1992	CA2109206A1 Treatment of liver cancer
11/26/1992	CA2108880A1 Treatment of fatigue syndrome with cholinesterase inhibitors
11/26/1992	CA2108767A1 Tumor associated monoclonal antibody 81av78
11/26/1992	CA2108754A1 Endothelin antagonists
11/26/1992	CA2103376A1 Purification and cloning of p62
11/26/1992	CA2103159A1 Cloning and expression of human islet glutamic acid decarboxylase autoantigen
11/26/1992	CA2103064A1 Targeted delivery of genes encoding immunogenic proteins
11/26/1992	CA2102704A1 Inhibitor of nf-kb transcriptional activator and uses thereof
11/26/1992	CA2102607A1 Enzyme systems
11/26/1992	CA2102514A1 Composition and method of treating depigmentation disorders
11/26/1992	CA2102195A1 Atp-dependent protease and use of inhibitors for same in the treatment of cachexia and muscle wasting
11/26/1992	CA2086676A1 Grf analogs xi
11/26/1992	CA2086327A1 Cloning and recombinant production of receptor(s) of the activin/tgf- .beta. superfamily
11/25/1992	EP0515301A2 Improvements in benzodiazepine treatment by cholinesterterase inhibitors

1 ... 2954 2955 2956 2957 2958 2959 2960 2961 2962 2963 2964 2965 2966 2967 2968 2969 2970 2971 2972 2973 2974 ... 3163